Assessment of Medium-Term Impact of Sars-Cov2 Infection on Pulmonary Function in Albanian Young Adults without Previous History of Respiratory Disease

Etleva Qirko  Loloci; Anxhela Gurakuqi  Qirko; Eralda  Lekli; Elizana  Petrela; Nertila  Beqo; Albana  Gjeli; Mehmet Hoxha

doi:10.3889/oamjms.2023.11556

Authors

Etleva Qirko Loloci Department of Internal Medicine, Faculty of Medicine, University of Medicine, Tirana, Albania
Anxhela Gurakuqi Qirko Department of Biomedical and Experimental Sciences, Faculty of Medicine, University of Medicine, Tirana, Albania https://orcid.org/0000-0002-8416-5886
Eralda Lekli Department of Biomedical and Experimental Sciences, Faculty of Medicine, University of Medicine, Tirana, Albania https://orcid.org/0000-0003-3041-8910
Elizana Petrela Department of Public Health, Biostatistic sector, Faculty of Medicine, University of Medicine, Tirana, Albania
Nertila Beqo Department of Internal Medicine, Faculty of Medicine, University of Medicine, Tirana, Albania
Albana Gjeli Department of Internal Medicine, Faculty of Medicine, University of Medicine, Tirana, Albania https://orcid.org/0000-0001-9365-0798
Mehmet Hoxha Department of Internal Medicine, Faculty of Medicine, University of Medicine, Tirana, Albania

DOI:

https://doi.org/10.3889/oamjms.2023.11556

Keywords:

Pulmonary Function, Young adults, Albania, COVID-19, Bronchial hyper reactivity

Abstract

BACKGROUND: No study has been conducted to allow the evaluation of pulmonary dysfunction in Albanian population after medium-severe COVID-19 disease.

AIM: We aimed through this project to overview the spirometry data and correlation to other inflammatory markers in post COVID-19 young adults.

METHODS: A cross-sectional study was performed to access spirometry as pulmonary function test 3–6 months after COVID-19 in young adults ≤45 years old, hospitalized for COVID-19, and presented no known history for previous pulmonary disease.

RESULTS: Among 61 patients, 41 (67.2%) females; mean age 30.6 ± 8.63 years, have undergone a spirometry test 3–6 months after COVID-19. Spirometry data for pulmonary function resulted: 4 patients (6.56%) with pulmonary dysfunction, among them 1 patient (1.64%) Forced expiratory volume in 1 s (FEV1)/Forced vital capacity (FVC) <75%, with generalized bronchial obstruction and 3 patients (4.92%) with small airway obstruction (brochiolo-obstruction), FEF 25–75 <60%. According to criteria classification for disease, severity (SpO <94% and/or pulmonary infiltrates >50%) 22 (36.06%) had severe COVID-19. Among two groups of COVID severity, resulted statistically significant (p < 0.05), the difference for visual analogue scale (VAS) for dyspnea perception reported during 1st month post- COVID-19 after 6 min moderate physical activity and FEV1/FVC (Tiffeneau Index value) resulted no statistically significant changes between groups for inflammatory markers such as C reactive protein level, absolute lymphocyte count, FEF 25–75 or body mass index. D-dimer value had statistically significant change between two groups of COVID-19 severity. In two groups where present VAS dyspnea perception (≤5) and (>5), no significant correlation was found regarding FEV1/FVC and FEF 25–75 values among groups.

CONCLUSION: The results show that there are few patients that show obstructive pulmonary dysfunction evaluated by spirometry. As investigated by other published studies probably the effects in pulmonary function are improved after few months and bronchial hyper-reactivity post- COVID-19 needs further investigation.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Pazukhina E, Andreeva M, Spiridonova E, Bobkova P, Shikhaleva A, El-Taravi Y, et al. Prevalence and risk factors of post-COVID-19 condition in adults and children at 6 and 12 months after hospital discharge: A prospective, cohort study in Moscow (StopCOVID). BMC Med. 2022;20(1):244. https://doi.org/10.1186/s12916-022-02448-4 PMid:35794549 DOI: https://doi.org/10.2139/ssrn.4020142

Gao YD, Ding M, Dong X, Zhang JJ, Azkur AK, Azkur D, et al. Risk factors for severe and critically ill COVID-19 patients: A review. Allergy. 2021;76(2):428-55. https://doi.org/10.1111/all.14657 PMid:33185910 DOI: https://doi.org/10.1111/all.14657

Munblit D, Bobkova P, Spiridonova E, Shikhaleva A, Gamirova A, Blyuss O, et al. Incidence and risk factors for persistent symptoms in adults previously hospitalized for COVID-19. Clin Exp Allergy. 2021;51(9):1107-20. https://doi.org/10.1111/cea.13997 PMid:34351016 DOI: https://doi.org/10.1111/cea.13997

Larsson SC, Gill D. Genetic predisposition to allergic diseases is inversely associated with risk of COVID-19. Allergy.

;76(6):1911-3. https://doi.org/10.1111/all.14728 PMid:33382452 DOI: https://doi.org/10.1111/all.14728

Blumfield E, Levin TL, Kurian J, Lee EY, Liszewski MC. Imaging findings in multisystem inflammatory syndrome in children (MIS-C) associated with Coronavirus disease (COVID-19). Am J Roentgenol. 2021;216(2):507-17. https://doi.org/10.2214/AJR.20.24032 PMid:32755212 DOI: https://doi.org/10.2214/AJR.20.24032

Strazda G, Ieviņa M, Madaja O, Jurka N, Gordjusina V, Taivans I. Evaluation of bronchial hyperreactivity in patients after Covid-19 infection. Eur Respir J. 2022;60:338. https://doi.org/10.1183/13993003.congress-2022.338 DOI: https://doi.org/10.1183/13993003.congress-2022.338

Munker D, Veit T, Barton J, Mertsch P, Mümmler C, Osterman A, et al. Pulmonary function impairment of asymptomatic and persistently symptomatic patients 4 months after COVID-19 according to disease severity. Infection. 2022;50(1):157-68. https://doi.org/10.1007/s15010-021-01669-8 PMid:34322859 DOI: https://doi.org/10.1007/s15010-021-01669-8

Ahmeidi AA, Musa A, Ahmed HS, Elahmar AA, Goota RB, Ahmed IA, et al. Inflammatory markers as predictors of mortality in COVID-19 infection. Afr J Lab Med. 2020;9(1):1298. https://doi.org/10.4102/ajlm.v9i1.1298 PMid:33392056 DOI: https://doi.org/10.4102/ajlm.v9i1.1298

Tarraso J, Safont B, Carbonell-Asins JA, Fernandez- Fabrellas E, Sancho-Chust JN, Naval E, et al. Lung function and radiological findings 1 year after COVID-19: A prospective follow-up. Respir Res. 2022;23(1):242. https://doi.org/10.1186/s12931-022-02166-8 PMid:36096801 DOI: https://doi.org/10.1186/s12931-022-02166-8

Zhang H, Li X, Huang L, Gu X, Wang Y, Liu M, et al. Lung-function trajectories in COVID-19 survivors after discharge: A two-year longitudinal cohort study. EClinicalMedicine. 2022;54:101668. https://doi.org/10.1016/j.eclinm.2022.101668 PMid:36188433 DOI: https://doi.org/10.1016/j.eclinm.2022.101668

Mogensen I, Hallberg J, Björkander S, Du L, Zuo F, Hammarström L, et al. Lung function before and after COVID-19 in young adults: A population-based study. J Allergy Clin Immunol Glob. 2022;1(2):37-42. https://doi.org/10.1016/j.jacig.2022.03.001 PMid:36647376 DOI: https://doi.org/10.1016/j.jacig.2022.03.001

Bode SF, Haendly M, Fabricius D, Mayer B, Zernickel M, Haddad AD, et al. Pulmonary function and persistent clinical symptoms in children and their parents 12 months after mild SARS-CoV-2 infection. Front pediatr. 2022;10:894331. https://doi.org/10.3389/fped.2022.894331 PMid:3584473 DOI: https://doi.org/10.3389/fped.2022.894331

Shah S, Shah K, Patel SB, Patel FS, Osman M, Velagapudi P, et al. Elevated D-dimer levels are associated with increased risk of mortality in Coronavirus disease 2019: A systematic review and meta-analysis. Cardiol Rev. 2020;28(6):295-302. https://doi.org/10.1097/CRD.0000000000000330 PMid:33017364 DOI: https://doi.org/10.1097/CRD.0000000000000330

Lehmann A, Prosch H, Zehetmayer S, Gysan MR, Bernitzky D, Vonbank K, et al. Impact of persistent D-dimer elevation following recovery from COVID-19. PLoS One. 2021;16(10):e0258351. https://doi.org/10.1371/journal.pone.0258351 PMid:34710097 DOI: https://doi.org/10.1371/journal.pone.0258351

Lehmann A, Gysan M, Bernitzky D, Bal C, Prosch H, Zehetmayer S, et al. Comparison of pulmonary function test, diffusion capacity, blood gas analysis and CT scan in patients with and without persistent respiratory symptoms following COVID-19. BMC Pulm Med. 2022;22(1):196. https://doi.org/10.1186/s12890-022-01987-z PMid:35578190 DOI: https://doi.org/10.1186/s12890-022-01987-z

Back GD, Oliveira MR, Camargo PF, Goulart CL, Oliveira CR, Wende KW, et al. Mild-to-moderate COVID-19 impact on the cardiorespiratory fitness in young and middle-aged populations. Braz J Med Biol Res. 2022;55:e12118. https://doi.org/10.1590/1414-431X2022e12118 PMid:35857999 DOI: https://doi.org/10.1590/1414-431x2022e12118

Ye L, Yao G, Lin S, Fang Y, Chen X, Wang L, et al. The investigation of pulmonary function changes of COVID-19 patients in three months. J Healthc Eng. 2022;2022:9028835. https://doi.org/10.1155/2022/9028835 PMid:35047158 DOI: https://doi.org/10.1155/2022/9028835

Polese J, Sant’Ana L, Moulaz IR, Lara IC, Bernardi JM, de Lima MD, et al. Pulmonary function evaluation after hospital discharge of patients with severe COVID-19. Clinics (Sao Paulo). 2021;76:e2848. https://doi.org/10.6061/clinics/2021/e2848 PMid:34190851 DOI: https://doi.org/10.6061/clinics/2021/e2848

Krueger T, van den Heuvel J, den Boogaart VV, van Zeeland R, Mehagnoul-Schipper DJ, Barten DG, et al. Pulmonary function three to five months after hospital discharge for COVID-19: A single centre cohort study. Sci Rep. 2023;13(1):681. https://doi.org/10.1038/s41598-023-27879-8 PMid:36639404 DOI: https://doi.org/10.1038/s41598-023-27879-8

Sibila O, Albacar N, Perea L, Faner R, Torralba Y, Hernandez- Gonzalez F, et al. Lung function sequelae in COVID-19 patients 3 months after hospital discharge. Arch Bronconeumol. 2021;57:59-61. https://doi.org/10.1016/j.arbres.2021.01.036 PMid:34629656 DOI: https://doi.org/10.1016/j.arbres.2021.01.036